| Villacis Eyecare Llc | |
|
1320 W Main St, Waterbury, CT 06708-3119 | |
| (203) 755-4941 | |
| (203) 573-8372 |
| Full Name | Villacis Eyecare Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1320 W Main St, Waterbury, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437790151 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Albert E Germain |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1841236122 PECOS PAC ID: 9537348792 Enrollment ID: I20110120000850 |
News Archive
New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.
UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.
Results of a national survey point to a greater need to educate women on the risks associated with early elective cesarean sections and labor inductions.
Researchers at Keele University in the UK have been awarded a £1.93 million National Institute of Health Research (NIHR) Programme Grant for a new five year programme of research to develop a new treatment model for people with musculoskeletal problems in primary care, in which treatment will be tailored to patients' risk of persistent pain and disability.
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
› Verified 1 days ago
| Provider Name | Fabian Cesar Villacis |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1386939510 PECOS PAC ID: 3476798018 Enrollment ID: I20130402000117 |
News Archive
New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.
UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.
Results of a national survey point to a greater need to educate women on the risks associated with early elective cesarean sections and labor inductions.
Researchers at Keele University in the UK have been awarded a £1.93 million National Institute of Health Research (NIHR) Programme Grant for a new five year programme of research to develop a new treatment model for people with musculoskeletal problems in primary care, in which treatment will be tailored to patients' risk of persistent pain and disability.
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
› Verified 1 days ago
| Provider Name | Kellee E Adams |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1427311950 PECOS PAC ID: 1153612692 Enrollment ID: I20160614001060 |
News Archive
New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.
UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.
Results of a national survey point to a greater need to educate women on the risks associated with early elective cesarean sections and labor inductions.
Researchers at Keele University in the UK have been awarded a £1.93 million National Institute of Health Research (NIHR) Programme Grant for a new five year programme of research to develop a new treatment model for people with musculoskeletal problems in primary care, in which treatment will be tailored to patients' risk of persistent pain and disability.
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
› Verified 1 days ago
| Provider Name | Nicole Adam |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1225612682 PECOS PAC ID: 7618343252 Enrollment ID: I20221021002069 |
News Archive
New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.
UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.
Results of a national survey point to a greater need to educate women on the risks associated with early elective cesarean sections and labor inductions.
Researchers at Keele University in the UK have been awarded a £1.93 million National Institute of Health Research (NIHR) Programme Grant for a new five year programme of research to develop a new treatment model for people with musculoskeletal problems in primary care, in which treatment will be tailored to patients' risk of persistent pain and disability.
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Villacis Eyecare Llc 1320 W Main St, Waterbury, CT 06708-3119 Ph: (203) 755-4941 | Villacis Eyecare Llc 1320 W Main St, Waterbury, CT 06708-3119 Ph: (203) 755-4941 |
News Archive
New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.
UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.
Results of a national survey point to a greater need to educate women on the risks associated with early elective cesarean sections and labor inductions.
Researchers at Keele University in the UK have been awarded a £1.93 million National Institute of Health Research (NIHR) Programme Grant for a new five year programme of research to develop a new treatment model for people with musculoskeletal problems in primary care, in which treatment will be tailored to patients' risk of persistent pain and disability.
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
› Verified 1 days ago
Dr. Dana Lynn Shepard, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3600 E Main St, Waterbury, CT 06705 Phone: 203-596-0406 | |
Dana L Shepard Od & Associates Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3600 E Main St, Waterbury, CT 06705 Phone: 203-596-0406 | |
Dr Binh Moore And Associates Llc Optometrist Medicare: Medicare Enrolled Practice Location: 425 Union St, Waterbury, CT 06706 Phone: 203-757-7120 | |
Dr. Audrey S Fung, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3600 E Main St, Waterbury, CT 06705 Phone: 203-596-0406 Fax: 203-756-7316 | |
Dr. John Joseph Pulaski, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 625 Wolcott St, Waterbury, CT 06705 Phone: 203-754-8339 Fax: 203-753-9030 | |
Dr. Frank Restivo, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 495 Union St Ste 1082, Waterbury, CT 06706 Phone: 203-591-8353 | |
Eyecare Center Of Waterbury Llc Optometrist Medicare: Medicare Enrolled Practice Location: 625 Wolcott St, Waterbury, CT 06705 Phone: 203-754-8339 |